Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Suzetrigine Within an ERAS Protocol for DIEP Flap Breast Reconstruction: A Randomized Controlled Trial

NCT07839715 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT07839715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07839715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Suzetrigine Within an ERAS Protocol for DIEP Flap Breast Reconstruction: A Randomized Controlled Trial
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
August 31, 2027
Enrollment
198 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diep flap, diep flap breast reconstruction, eras, opioid, post-operative pain, suzetrigine